APA (7th ed.) Citation

Rugo, H. S., Bardia, A., Marmé, F., Cortes, J., Schmid, P., Loirat, D., . . . Tolaney, S. M. (2022). Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. Journal of clinical oncology, 40(29), . https://doi.org/10.1200/JCO.22.01002

Chicago Style (17th ed.) Citation

Rugo, Hope S., et al. "Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer." Journal of Clinical Oncology 40, no. 29 (2022). https://doi.org/10.1200/JCO.22.01002.

MLA (9th ed.) Citation

Rugo, Hope S., et al. "Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer." Journal of Clinical Oncology, vol. 40, no. 29, 2022, https://doi.org/10.1200/JCO.22.01002.